Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.23/917 |
Resumo: | Sequelae of the traumatic injuries to the spinal cord represent a high personal, family and social damage. Since 1984, it has been investigated and considered that the treatment with sodium succinate methylprednisolone in high doses was a solution to revert or to prevent the aggravation of such injuries. We present a revision of literature on this subject. It is well established that this therapeutic has a high rate of complications, but concerning its advantages and real effectiveness, there is no agreement between paper authors. While some defend it, others state that this is a total contraindication in this pathology. There are already some medical centers worldwide that do not use it. In Portugal, the practice of its administration is generalized. Not to do it could be difficult to defend in a litigation situation. But are we really helping our patients with it? |
id |
RCAP_1752aea7052b0fa1efd25fc802504205 |
---|---|
oai_identifier_str |
oai:repositorio.hospitaldebraga.pt:10400.23/917 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo?High dose of corticotherapy for spinal cord injuries. Is it a benefit or not?Traumatismos da Medula EspinalCorticosteróidesSequelae of the traumatic injuries to the spinal cord represent a high personal, family and social damage. Since 1984, it has been investigated and considered that the treatment with sodium succinate methylprednisolone in high doses was a solution to revert or to prevent the aggravation of such injuries. We present a revision of literature on this subject. It is well established that this therapeutic has a high rate of complications, but concerning its advantages and real effectiveness, there is no agreement between paper authors. While some defend it, others state that this is a total contraindication in this pathology. There are already some medical centers worldwide that do not use it. In Portugal, the practice of its administration is generalized. Not to do it could be difficult to defend in a litigation situation. But are we really helping our patients with it?Repositório Científico do Hospital de BragaBandeira-Rodrigues, EDuarte, RMaia, JVaz, HPereira, E2015-07-01T13:51:28Z2010-01-01T00:00:00Z2010-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.23/917porCOLUNA/COLUMNA. 2010;9(4):462-465info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-21T09:02:41Zoai:repositorio.hospitaldebraga.pt:10400.23/917Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:55:31.606958Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo? High dose of corticotherapy for spinal cord injuries. Is it a benefit or not? |
title |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo? |
spellingShingle |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo? Bandeira-Rodrigues, E Traumatismos da Medula Espinal Corticosteróides |
title_short |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo? |
title_full |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo? |
title_fullStr |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo? |
title_full_unstemmed |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo? |
title_sort |
Corticoterapia em altas doses no traumatizado medular – benefício ou prejuízo? |
author |
Bandeira-Rodrigues, E |
author_facet |
Bandeira-Rodrigues, E Duarte, R Maia, J Vaz, H Pereira, E |
author_role |
author |
author2 |
Duarte, R Maia, J Vaz, H Pereira, E |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Hospital de Braga |
dc.contributor.author.fl_str_mv |
Bandeira-Rodrigues, E Duarte, R Maia, J Vaz, H Pereira, E |
dc.subject.por.fl_str_mv |
Traumatismos da Medula Espinal Corticosteróides |
topic |
Traumatismos da Medula Espinal Corticosteróides |
description |
Sequelae of the traumatic injuries to the spinal cord represent a high personal, family and social damage. Since 1984, it has been investigated and considered that the treatment with sodium succinate methylprednisolone in high doses was a solution to revert or to prevent the aggravation of such injuries. We present a revision of literature on this subject. It is well established that this therapeutic has a high rate of complications, but concerning its advantages and real effectiveness, there is no agreement between paper authors. While some defend it, others state that this is a total contraindication in this pathology. There are already some medical centers worldwide that do not use it. In Portugal, the practice of its administration is generalized. Not to do it could be difficult to defend in a litigation situation. But are we really helping our patients with it? |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-01-01T00:00:00Z 2010-01-01T00:00:00Z 2015-07-01T13:51:28Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.23/917 |
url |
http://hdl.handle.net/10400.23/917 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
COLUNA/COLUMNA. 2010;9(4):462-465 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130424301060096 |